| Product Code: ETC6738760 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Cancer Therapy Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Cancer Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 China Cancer Therapy Market - Industry Life Cycle |
3.4 China Cancer Therapy Market - Porter's Five Forces |
3.5 China Cancer Therapy Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 China Cancer Therapy Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 China Cancer Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Cancer Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in China |
4.2.2 Growing demand for advanced cancer therapies |
4.2.3 Government initiatives to improve cancer treatment infrastructure |
4.3 Market Restraints |
4.3.1 High cost of cancer therapies |
4.3.2 Stringent regulations and approval processes for new treatments |
5 China Cancer Therapy Market Trends |
6 China Cancer Therapy Market, By Types |
6.1 China Cancer Therapy Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 China Cancer Therapy Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 China Cancer Therapy Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.4 China Cancer Therapy Market Revenues & Volume, By Target Therapy, 2021- 2031F |
6.1.5 China Cancer Therapy Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.6 China Cancer Therapy Market Revenues & Volume, By Hormone Therapy, 2021- 2031F |
6.1.7 China Cancer Therapy Market Revenues & Volume, By Other Treatment Types, 2021- 2031F |
6.2 China Cancer Therapy Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 China Cancer Therapy Market Revenues & Volume, By Blood Cancer, 2021- 2031F |
6.2.3 China Cancer Therapy Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.4 China Cancer Therapy Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.5 China Cancer Therapy Market Revenues & Volume, By Gastrointestinal Cancer, 2021- 2031F |
6.2.6 China Cancer Therapy Market Revenues & Volume, By Gynecologic Cancer, 2021- 2031F |
6.2.7 China Cancer Therapy Market Revenues & Volume, By Respiratory/Lung Cancer, 2021- 2031F |
6.3 China Cancer Therapy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Cancer Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 China Cancer Therapy Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.4 China Cancer Therapy Market Revenues & Volume, By Cancer and Radiation Therapy Center, 2021- 2031F |
7 China Cancer Therapy Market Import-Export Trade Statistics |
7.1 China Cancer Therapy Market Export to Major Countries |
7.2 China Cancer Therapy Market Imports from Major Countries |
8 China Cancer Therapy Market Key Performance Indicators |
8.1 Number of cancer cases diagnosed annually in China |
8.2 Adoption rate of innovative cancer therapies in the market |
8.3 Investment in research and development for cancer treatments |
8.4 Patient survival rates after receiving therapy |
8.5 Number of cancer treatment facilities and oncologists in China |
9 China Cancer Therapy Market - Opportunity Assessment |
9.1 China Cancer Therapy Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 China Cancer Therapy Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 China Cancer Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Cancer Therapy Market - Competitive Landscape |
10.1 China Cancer Therapy Market Revenue Share, By Companies, 2024 |
10.2 China Cancer Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here